| CRSP Snapshot | |
|---|---|
| CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases. The company is headquartered in Zug, Switzerland. | |
| VALUATION DATA | |
| Market Capitalization | $4,840,883,000 | Price to Sales | 12.00 |
| Earnings per Share | $-1.9400 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $55.6500 |
| 52 Week High | $13.87 |
| 52 Week Low | $2.735 |
| 50-Day Moving Average | $9.99 |
| 200-Day Moving Average | $-18.23 |
| All data are from Alpha Vantage as of today. For more infomation on CRSP see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search